ArticleCellular and molecular life sciences : CMLS2023

Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot-Marie-Tooth type 2A.

Federica Rizzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.